A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
| Status: | Completed |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/15/2018 |
| Start Date: | May 21, 2012 |
| End Date: | July 23, 2013 |
A One-Year, Open-Label Study With Teduglutide for Subjects With Parenteral Nutrition-dependent Short Bowel Syndrome Who Completed Study CL0600-021
This study is a 1-year open label extension study to collect long term efficacy and safety
data from patients who have completed approximately 2 years of dosing in Study CL0600-021.
data from patients who have completed approximately 2 years of dosing in Study CL0600-021.
This study served as a 1-year extension study for those US patients who have completed the
CL0600-021 study.
CL0600-021 study.
Inclusion Criteria:
- At completion of Study CL0600-021, subjects will be invited to participate in this
trial if they meet the following criteria:
1. Completion of the 24-month study, CL0600-021, regardless if fully weaned from
PN/I.V. support
2. Signed and dated informed consent form (ICF) to participate before any
study-related procedures of Study TED-C11-001 are performed
Exclusion Criteria:
We found this trial at
5
sites
1211 Medical Center Dr
Nashville, Tennessee 37232
Nashville, Tennessee 37232
(615) 322-5000
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
Click here to add this to my saved trials
Emory University School of Medicine Emory University School of Medicine has 2,359 full- and part-time...
Click here to add this to my saved trials
Mount Sinai Med Ctr Founded in 1852, The Mount Sinai Hospital is a 1,171-bed, tertiary-care...
Click here to add this to my saved trials
Click here to add this to my saved trials
Univ of Pennsylvania Penn has a long and proud tradition of intellectual rigor and pursuit...
Click here to add this to my saved trials